Neural Stem Cell-based Gene Therapy for Brain Tumors
Author:
- 3 June 2010
- journal article
- research article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 7 (1) , 130-140
Abstract
Advances in gene-based medicine since 1990s have ushered in new therapeutic strategy of gene therapy for inborn error genetic diseases and cancer. Malignant brain tumors such as glioblastoma multiforme and medulloblastoma remain virtually untreatable and lethal. Currently available treatment for brain tumors including radical surgical resection followed by radiation and chemotherapy, have substantially improved the survival rate in patients suffering from these brain tumors; however, it remains incurable in large proportion of patients. Therefore, there is substantial need for effective, low-toxicity therapies for patients with malignant brain tumors, and gene therapy targeting brain tumors should fulfill this requirement. Gene therapy for brain tumors includes many therapeutic strategies and these strategies can be grouped in two major categories: molecular and immunologic. The widely used molecular gene therapy approach is suicide gene therapy based on the conversion of non-toxic prodrugs into active anticancer agents via introduction of enzymes and genetic immunotherapy involves the gene transfer of immune-stimulating cytokines including IL-4, IL-12 and TRAIL. For both molecular and immune gene therapy, neural stem cells (NSCs) can be used as delivery vehicle of therapeutic genes. NSCs possess an inherent tumor tropism that supports their use as a reliable delivery vehicle to target therapeutic gene products to primary brain tumors and metastatic cancers throughout the brain. Significance of the NSC-based gene therapy for brain tumor is that it is possible to exploit the tumor-tropic property of NSCs to mediate effective, tumor-selective therapy for primary and metastatic cancers in the brain and outside, for which no tolerated curative treatments are currently available.Keywords
This publication has 125 references indexed in Scilit:
- Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic AntibodiesPLOS ONE, 2009
- Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma ModelPLOS ONE, 2009
- c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brainBMC Neuroscience, 2009
- Stem cell‐based cell therapy in neurological diseases: A reviewJournal of Neuroscience Research, 2009
- Human Neural Stem Cells Can Target and Deliver Therapeutic Genes to Breast Cancer Brain MetastasesMolecular Therapy, 2009
- Human Neural Stem Cells Over-Expressing VEGF Provide Neuroprotection, Angiogenesis and Functional Recovery in Mouse Stroke ModelPLOS ONE, 2007
- Development of a Tumor-Selective Approach to Treat Metastatic CancerPLOS ONE, 2006
- Identification ofCXCR4as a New Nitric Oxide-Regulated Gene in Human CD34+ CellsStem Cells, 2006
- Induction of the interferon response by siRNA is cell type– and duplex length–dependentRNA, 2006
- Stem and progenitor cell–based therapy of the human central nervous systemNature Biotechnology, 2005